Skip to main content

Peer Review reports

From: TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle

Original Submission
8 Nov 2022 Submitted Original manuscript
8 May 2023 Reviewed Reviewer Report
11 May 2023 Reviewed Reviewer Report
31 May 2023 Author responded Author comments - Xiaoqing Xi
Resubmission - Version 2
31 May 2023 Submitted Manuscript version 2
19 Jun 2023 Author responded Author comments - Xiaoqing Xi
Resubmission - Version 3
19 Jun 2023 Submitted Manuscript version 3
3 Jul 2023 Reviewed Reviewer Report
20 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
23 Jul 2023 Editorially accepted
1 Aug 2023 Article published 10.1186/s12885-023-11209-2

You can find further information about peer review here.

Back to article page